Taking people in United KingdomNo phase
Endovascular AAA Intervention Using the GORE® EXCLUDER® Conformable AAA Endoprosthesis or Iliac Branch Endoprosthesis
Key facts
- Who runs it
- W.L.Gore & Associates
- Where
- Leicester, Liverpool, and London, United KingdomSee the 4 sitesAlso in 12 other countries, 70 sites
- Trial code
- Status
- Recruiting
- People taking part
- 2,000 people, planned
- Started
- 7 May 2024
- Expected to end
- 30 Sept 2042
- Type of study
- Observational, 2 groups
- Record updated
- 12 November 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 6 criteriaShow less
Who can take part
- Patient or legally authorized representative (LAR) provides written authorization and/or consent per institution and geographical requirements
- Patient has been or is intended to be treated with an eligible registry device
- Patient is age ≥ 18 years at time of informed consent signature
Who cannot take part
- Patient is currently enrolled in or plans to enroll in any concurrent drug and/or device study within 12 months of Together Registry enrollment. Subjects cannot be enrolled in another Together Registry module protocol
- Patient who is, at the time of consent, unlikely to be available for standard of care (SOC) follow-up visits as defined by the site's guidelines and procedures
- Patient with exclusion criteria required by local law
Where in United Kingdom
Also in 12 other countries, 70 sites
- University Hospitals of Leicester NHS TrustLeicester, United KingdomContact: Gregory McMahonTaking people
- Countess of Chester Hospital NHS Foundation TrustLiverpool, United KingdomContact: Leith WilliamsTaking people
- Imperial College Healthcare NHS Trust, St. Mary's HospitalLondon, United KingdomContact: Colin BicknellTaking people
- St Thomas Hospital - Guys and St. Thomas' NHSLondon, United KingdomContact: Said AbisiTaking people
About the trial
What the trial wants to find out
A prospective, observational post-market registry collecting outcomes through a 10-year post procedure follow-up for patients treated with the GORE® EXCLUDER® Conformable AAA Endoprosthesis (EXCC Device) or the GORE® EXCLUDER® Iliac Branch Endoprosthesis (IBE Device) as a part of routine clinical practice.
The 2 groups in the trial
- GORE® EXCLUDER® Conformable AAA Endoprosthesis (EXCC Device)
Patients treated with the EXCC Device
- GORE® EXCLUDER® Iliac Branch Endoprosthesis (IBE Device)
Patients treated with the IBE Device
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Assessment of Long Term, Endovascular AAA Intervention Using the GORE® EXCLUDER® Conformable AAA Endoprosthesis or Iliac Branch Endoprosthesis
- Record updated
- 12 November 2026